Literature DB >> 2644850

Role of renal sympathetic nerves in renin inhibition by elevated left atrial pressure.

D A Scheuer1, T N Thrasher, D J Ramsay.   

Abstract

We have reported that the renin response to systemic hypotension during a simultaneous increase in left atrial pressure (LAP) depends, in part, on intact renal nerves. Because efferent neural control of renin release is mediated by renal sympathetic nerves, we tested the hypothesis that withdrawal of renal sympathetic tone is an essential component of the inhibitory mechanism. In conscious dogs, the ascending aorta was partially constricted to produce a simultaneous decrease, of up to 30%, in renal perfusion pressure (RPP) and a rise in LAP. Sympathetic neural control of renin release was reversibly blocked with propranolol. Propranolol infusion did not affect the increases in LAP or atrial natriuretic factor (ANF) during ascending aortic constriction. There was no increase in renin (P greater than 0.1) during ascending aortic constriction, with or without propranolol infusion. Identical reductions in RPP during constriction of the abdominal aorta caused renin to rise (P less than 0.03). Therefore acute withdrawal of renal sympathetic tone is not necessary for the inhibition of the renin response to systemic hypotension by elevated LAP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2644850     DOI: 10.1152/ajpregu.1989.256.2.R413

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

Review 1.  Multimodality Imaging in the Study of the Left Atrium.

Authors:  Sergio Moral; Marc Abulí; Pau Vilardell; Emilce Trucco; Esther Ballesteros; Ramon Brugada
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

Review 2.  Left atrial remodelling contributes to the progression of asymptomatic left ventricular systolic dysfunction to chronic symptomatic heart failure.

Authors:  George Karayannis; George Kitsios; Haralambos Kotidis; Filippos Triposkiadis
Journal:  Heart Fail Rev       Date:  2007-04-21       Impact factor: 4.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.